CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 642 enrolled
Drug / intervention
nicotine lozenge +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00365508
NCT00365508Phase 4Completed
CompareCT.gov

Comparing the Lozenge to the Patch for Smoking Cessation

Fox Chase Cancer Center·interventional·Posted Aug 17, 2006·Updated Mar 29, 2016

In Brief

A Phase 4 clinical trial evaluating nicotine lozenge and nicotine patch for Bladder Cancer and 10 related conditions. Completed, enrolled 642 participants across 10 sites.

Detailed Summary

RATIONALE: Stop-smoking plans, including counseling and nicotine replacement therapy, may help smokers quit smoking. It is not yet known whether counseling and the nicotine lozenge is more effective than counseling and the nicotine patch in helping adult smokers quit smoking. PURPOSE: This randomized phase III trial is studying counseling and the nicotine lozenge to see how well they work compared to counseling and the nicotine patch in helping smokers quit smoking.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 17, 2006
Enrollment StartFeb 1, 2006
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 19.9 years ago

Interventions

nicotine lozengedrug

nicotine lozenge

nicotine patchdrug

transdermal nicotine patch